EUVIMEDEUVIMED entdecken
EditorialOpen Access

Evidence from a Bayesian reanalysis of the iPROVE-OLV study: is it time to update our prior assumptions regarding neuromuscular block and reversal?

Douglas A Colquhoun, Manfred Blobner

British Journal of Anaesthesia · 2025-11 · 135 (5) · 1391-1393

DOI: 10.1016/j.bja.2025.04.003 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Anaesthesia, 2025-11. Verfasst von Douglas A Colquhoun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, NI, USA. Electronic address: dougcolq@med.umich.edu. Hauptthemen laut MEDLINE: Neuromuscular Blockade. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a Bayesian secondary analysis of a subset of 698 patients in the iPROVE-OLV study, Mazzinari and colleagues report evidence of benefit for the use of neuromuscular monitoring and reversal under a range of prior assumptions (i.e. assumptions of probability of benefit or harm). This is a secondary analysis of the iPROVE-OLV study, a 1308-patient RCT of individualised PEEP and postoperative high-flow nasal cannula oxygen in patients undergoing thoracic surgery. However, detailed information on monitoring modalities and reversal agent dosage, which could impact practice, were not available for analysis. Recent practice guidelines, published by both European and American professional societies have supported routine use of quantitative neuromuscular block and reversal. Practice surveys and observational analyses that predate these guidelines suggest that a significant gap between real world and guideline-recommended practice exists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromuscular BlockadeHumansBayes TheoremNeuromuscular MonitoringRandomized Controlled Trials as TopicPractice Guidelines as Topic

Stichwörter der Autor:innen

Bayesian analysisneostigmineneuromuscular blockpractice guidelinesreversalsugammadex

Autor:innen und Institutionen

  • Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, NI, USA. Electronic address: dougcolq@med.umich.edu.
  • Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ulm, Ulm, Germany.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Colquhoun, D. A., & Blobner, M. (2025). Evidence from a Bayesian reanalysis of the iPROVE-OLV study: is it time to update our prior assumptions regarding neuromuscular block and reversal?. British Journal of Anaesthesia, 135(5), 1391-1393. https://doi.org/10.1016/j.bja.2025.04.003

Vancouver

Colquhoun DA, Blobner M. Evidence from a Bayesian reanalysis of the iPROVE-OLV study: is it time to update our prior assumptions regarding neuromuscular block and reversal?. British Journal of Anaesthesia. 2025;135(5):1391-1393. doi:10.1016/j.bja.2025.04.003

BibTeX
@article{Colquhoun2025,
  author = {Colquhoun, Douglas A and Blobner, Manfred},
  title = {Evidence from a Bayesian reanalysis of the iPROVE-OLV study: is it time to update our prior assumptions regarding neuromuscular block and reversal?},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  volume = {135},
  number = {5},
  pages = {1391--1393},
  doi = {10.1016/j.bja.2025.04.003}
}
Kostenlos starten →